author-photo

Min Yan

Zhengzhou University

21

Papers

125

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Distress Thermometer in breast cancer: systematic review and meta-analysis.

2021 BMJ
Show All
- Source
- Cite
- Save
Citations (1)
Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer.

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (22)
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Clinical diagnosis and treatment of breast cancer with brain metastases and establishment of a prognostic model: a 10-year, single-center, real-world study of 559 cases

2021 Annals of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Gemcitabine or Abraxane Combined with cisPlatin (GAP) as First-Line Treatment in Patients with Metastatic Triple-Negative Breast Cancer: A Multicenter, Randomized, Open-Label, Phase 3 Trial

2020
Show All
- Source
- Cite
- Save
Citations (0)
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.

2020 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Pyrotinib plus capecitabine for HER2-positive, trastuzumab-resistant metastatic breast cancer: A pooled analysis of three randomized controlled trials.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)